Endologix Reports Second Quarter 2015 Financial Results
August 03, 2015 16:05 ET
|
Endologix
IRVINE, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
Endologix to Report Second Quarter 2015 Financial Results on August 3, 2015
July 09, 2015 16:05 ET
|
Endologix
IRVINE, Calif., July 9, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
Endologix Announces Promising Early Clinical Data From the Nellix EVAS FORWARD-IDE Clinical Study
June 17, 2015 11:00 ET
|
Endologix
IRVINE, Calif., June 17, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of 30-day...
Endologix to Present at the Jefferies 2015 Global Healthcare Conference
May 27, 2015 16:01 ET
|
Endologix
IRVINE, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Endologix to Participate in Two Investor Conferences in May
May 04, 2015 09:00 ET
|
Endologix
IRVINE, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Company management is...
Endologix Reports 10% Revenue Growth for the First Quarter 2015
April 29, 2015 16:05 ET
|
Endologix
IRVINE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
Positive Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at the 37th Annual Charing Cross Symposium
April 29, 2015 16:03 ET
|
Endologix
IRVINE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of updated...
Endologix Appoints Leslie Norwalk to Board of Directors
April 29, 2015 16:01 ET
|
Endologix
IRVINE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Leslie V. Norwalk, Esq.,...
Endologix to Report First Quarter 2015 Financial Results on April 29, 2015
April 13, 2015 09:00 ET
|
Endologix
IRVINE, Calif., April 13, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
Endologix Announces Chief Financial Officer Transition
March 12, 2015 09:00 ET
|
Endologix
IRVINE, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief...